Zentalis Pharmaceuticals, Inc. (ZNTL)
3.71
-0.05
(-1.33%)
USD |
NASDAQ |
Sep 01, 16:00
3.71
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Total Long Term Debt (Quarterly) : 33.56M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.56M |
| March 31, 2026 | 34.65M |
| December 31, 2025 | 35.70M |
| September 30, 2025 | 36.71M |
| June 30, 2025 | 37.69M |
| March 31, 2025 | 38.65M |
| December 31, 2024 | 39.58M |
| September 30, 2024 | 40.46M |
| June 30, 2024 | 41.32M |
| March 31, 2024 | 42.62M |
| December 31, 2023 | 43.15M |
| September 30, 2023 | 43.27M |
| June 30, 2023 | 44.03M |
| March 31, 2023 | 44.77M |
| December 31, 2022 | 45.17M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 44.46M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 1.097M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 155.93M |
| December 31, 2019 | 1.695M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 96.68M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |